These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17047580)

  • 1. Lafora disease.
    Madhavan D; Kuzniecky RI
    Rev Neurol Dis; 2006; 3(3):131-5. PubMed ID: 17047580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular genetics of epilepsy].
    Yamakawa K
    Rinsho Shinkeigaku; 2004 Nov; 44(11):858-60. PubMed ID: 15651314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lafora disease. A new case of confirmation of diagnosis on molecular genetic studies].
    Martínez-Bermejo A; López-Martín V; Serratosa JM; Gutiérrez-Molina M; Gómez-Garre P; Arcas J; Tendero A; Roche C; Pérez-Mies B
    Rev Neurol; 2002 Jan 16-31; 34(2):117-20. PubMed ID: 11988905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-convulsive epileptic status associated with Lafora disease: two case reports].
    Lopez-Meza EG; Cerda-Tellez F; Alanis-Guevara IM; Fernández González-Aragón MC; Ruano-Calderón LA
    Rev Neurol; 2003 Nov 16-30; 37(10):945-7. PubMed ID: 14634925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of pediatric epilepsy: European expert opinion, 2007.
    Wheless JW; Clarke DF; Arzimanoglou A; Carpenter D
    Epileptic Disord; 2007 Dec; 9(4):353-412. PubMed ID: 18077226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoclonic epilepsy masquerading as a tic disorder.
    Sethi NK; Labar D; Torgovnick J
    Clin Neurol Neurosurg; 2007 Jul; 109(6):509-11. PubMed ID: 17400368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myoclonic epilepsy of Lafora: a case report].
    Rudenskaia GE; Zakharova EIu; Karpin SL; Uchaev DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3 Suppl 2):11-6. PubMed ID: 20873469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation of an unusual patient with Lafora disease.
    Gökdemir S; Cağlayan H; Kızıltan M; Karaağaç N; Leblebici C; Yeni SN
    Epileptic Disord; 2012 Mar; 14(1):94-8. PubMed ID: 22425593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Late discovery of Lafora disease: a family study].
    Messouak O; Yahyaoui M; Benabdeljalil M; Benomar A; Ouazzani R; Amarti A; Saidi A; Chkili T
    Rev Neurol (Paris); 2002 Jan; 158(1):74-6. PubMed ID: 11938326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of epilepsy and electroencephalogram patterns in Wolf-Hirschhorn syndrome: experience with 87 patients.
    Battaglia A; Filippi T; South ST; Carey JC
    Dev Med Child Neurol; 2009 May; 51(5):373-80. PubMed ID: 19379291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of levetiracetam in refractory seizures due to a rare progressive myoclonic epilepsy: Lafora body disease.
    Hashmi M; Saleem F; Mustafa MS; Sheerani M; Ehtesham Z; Siddiqui K
    BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22791845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Typical progression of myoclonic epilepsy of the Lafora type: a case report.
    Striano P; Zara F; Turnbull J; Girard JM; Ackerley CA; Cervasio M; De Rosa G; Del Basso-De Caro ML; Striano S; Minassian BA
    Nat Clin Pract Neurol; 2008 Feb; 4(2):106-11. PubMed ID: 18256682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of unexpected and/or sudden death in Lafora disease.
    Wick R; Byard RW
    Forensic Sci Int; 2006 Nov; 163(1-2):144-7. PubMed ID: 16326059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe and rapidly-progressive Lafora disease associated with NHLRC1 mutation: a case report.
    Casciato S; Gambardella S; Mascia A; Quarato PP; D'Aniello A; Ackurina Y; Albano V; Fornai F; Scala S; Di Gennaro G
    Int J Neurosci; 2017 Dec; 127(12):1150-1153. PubMed ID: 28556688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Description of a family with a novel progressive myoclonus epilepsy and cognitive impairment.
    Ferlazzo E; Italiano D; An I; Calarese T; Laguitton V; Bramanti P; Di Bella P; Genton P
    Mov Disord; 2009 May; 24(7):1016-22. PubMed ID: 19243074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunctions in endosomal-lysosomal and autophagy pathways underlie neuropathology in a mouse model for Lafora disease.
    Puri R; Suzuki T; Yamakawa K; Ganesh S
    Hum Mol Genet; 2012 Jan; 21(1):175-84. PubMed ID: 21965301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progressive myoclonic epilepsy type Lafora].
    Chemaly R; Checrallah A; Trak-Smayra V; El-Kallab K; Chemaly E
    J Med Liban; 2001; 49(3):170-2. PubMed ID: 12187920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lafora's disease (EPM2)].
    Genton P
    Rev Neurol (Paris); 2007 Jan; 163(1):47-53. PubMed ID: 17304172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection.
    Engelsen BA; Tzoulis C; Karlsen B; Lillebø A; Laegreid LM; Aasly J; Zeviani M; Bindoff LA
    Brain; 2008 Mar; 131(Pt 3):818-28. PubMed ID: 18238797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel mutations in the EPM2A gene in a Korean patient with Lafora's progressive myoclonus epilepsy.
    Ki CS; Kong SY; Seo DW; Hong SB; Kim HJ; Kim JW
    J Hum Genet; 2003; 48(1):51-4. PubMed ID: 12560877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.